Analyzing Pfizer’s Return on Equity (ROE) (PFE) | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 5 March, 2016 by The TZ Newswire Staff

Analyzing Pfizer’s Return on Equity (ROE) (PFE)

Analyze the return on equity (ROE) of Pfizer and understand how changes in the company’s net margin have driven its ROE up and down recently.

See also
- Next Article This Medicare Benefit Is Often 100% Free — and It Saves You Money, Too
- Previous Article Analyzing Netflix’s Return on Equity (NFLX)
Editorial Calender

March 2016

M T W T F S S

1 2 3 4 5 6

7 8 9 10 11 12 13

14 15 16 17 18 19 20

21 22 23 24 25 26 27

28 29 30 31

« Feb Apr »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar